dennisdave,
I agree to a point that a partnership is needed and probably already pretty much lined up. However, there were those who financed the Cognate buyout and know Linda well. A former NWBO employee also was an advisor to Charles River Labs before their buyout of Cognate from managemant. Point being that Linda Powers has plenty of connections and more options than we might think.
Just the research institutions alone that were connected to the Phase 3 trial offer a significant base of contacts which if made aware that murcidencel is approved and receiving IFR patients at a high rate for many cancer types, would likely be kept in the loop with all advances made towards access at their facilities at very minimal cost to NWBO. Sawston will likely be an international training center and with Cambridge University right there the international draw and attention will be significant.
This reminds me about the land parcel that was not sold but was going to be developed into housing for employees if possible. Do you have any updates about what happened to that land that was around 17 acres I think? I lost track of its status. Best wishes.
Market Data 
Markets 
AI
